Class information for:
Level 1: FLAVOPIRIDOL//CELL CYCLE REGULAT GRP//ROSCOVITINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6779 1368 48.2 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
521 14318 CELL CYCLE//CDK5//E2F

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FLAVOPIRIDOL Author keyword 94 57% 8% 113
2 CELL CYCLE REGULAT GRP Address 34 65% 2% 33
3 ROSCOVITINE Author keyword 25 30% 5% 70
4 DINACICLIB Author keyword 19 80% 1% 12
5 CYC202 Author keyword 19 74% 1% 14
6 CYCLIN DEPENDENT KINASE Author keyword 15 14% 8% 103
7 PAULLONES Author keyword 15 68% 1% 13
8 CDK2 INHIBITOR Author keyword 15 88% 1% 7
9 DTP CLIN TRIALS UNIT Address 15 88% 1% 7
10 SELICICLIB Author keyword 12 58% 1% 14

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FLAVOPIRIDOL 94 57% 8% 113 Search FLAVOPIRIDOL Search FLAVOPIRIDOL
2 ROSCOVITINE 25 30% 5% 70 Search ROSCOVITINE Search ROSCOVITINE
3 DINACICLIB 19 80% 1% 12 Search DINACICLIB Search DINACICLIB
4 CYC202 19 74% 1% 14 Search CYC202 Search CYC202
5 CYCLIN DEPENDENT KINASE 15 14% 8% 103 Search CYCLIN+DEPENDENT+KINASE Search CYCLIN+DEPENDENT+KINASE
6 PAULLONES 15 68% 1% 13 Search PAULLONES Search PAULLONES
7 CDK2 INHIBITOR 15 88% 1% 7 Search CDK2+INHIBITOR Search CDK2+INHIBITOR
8 SELICICLIB 12 58% 1% 14 Search SELICICLIB Search SELICICLIB
9 CYCLIN DEPENDENT KINASES 12 17% 5% 64 Search CYCLIN+DEPENDENT+KINASES Search CYCLIN+DEPENDENT+KINASES
10 ALVOCIDIB 12 86% 0% 6 Search ALVOCIDIB Search ALVOCIDIB

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 L86 8275 125 97% 3% 35
2 CYC202 R ROSCOVITINE 58 73% 3% 45
3 FLAVOPIRIDOL 52 38% 8% 108
4 R ROSCOVITINE 51 56% 4% 61
5 OLOMOUCINE 46 64% 3% 45
6 SELICICLIB CYC202 29 63% 2% 30
7 72 HOUR CONTINUOUS INFUSION 28 68% 2% 25
8 DINACICLIB SCH 727965 27 92% 1% 11
9 ROSCOVITINE 27 34% 5% 66
10 FLAVOPIRIDOL INDUCED APOPTOSIS 23 86% 1% 12

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cyclin-dependent kinase pathways as targets for cancer treatment 2006 455 185 40%
CDK inhibitors in cancer therapy: what is next? 2008 152 31 68%
The history and future of targeting cyclin-dependent kinases in cancer therapy 2015 11 176 33%
The CDK inhibitors in cancer research and therapy 2011 63 78 58%
Cyclin dependent kinases in cancer Potential for therapeutic intervention 2012 38 61 69%
Cell cycle, CDKs and cancer: a changing paradigm 2009 832 164 13%
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs 2010 57 91 57%
Cell cycle kinases as therapeutic targets for cancer 2009 349 166 27%
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies 2013 16 109 68%
Pharmacological inhibitors of cyclin-dependent kinases 2002 379 76 41%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CELL CYCLE REGULAT GRP 34 65% 2.4% 33
2 DTP CLIN TRIALS UNIT 15 88% 0.5% 7
3 MOL THER EUT UNIT 7 46% 0.9% 12
4 HOTEL RECH 3 57% 0.3% 4
5 PROT PHOSPHORYLAT HUMAN DIS GRP 3 24% 0.9% 12
6 COMP AIDED DRUG DESIGNING MOL MODELING 3 50% 0.3% 4
7 CELL CYCLE REGULAT GRP CANC 2 67% 0.1% 2
8 CLIN TRIALS UNITMED BRANCH 2 67% 0.1% 2
9 GASTROINTESTINAL ONCOL SECT 2 67% 0.1% 2
10 BUSINESS UNIT ONCOL 2 26% 0.4% 6

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000199684 UCN 01//7 HYDROXYSTAUROSPORINE//7 HYDROXYSTAUROSPORINE UCN 01
2 0.0000135418 CHROMONE ALKALOIDS//ROHITUKINE//LDOC1
3 0.0000119094 CDK5//P35//CYCLIN DEPENDENT KINASE 5
4 0.0000110562 CYCLIN D1//CYCLIN E//CCND1
5 0.0000101659 KINETIN RIBOSIDE//BLADDER CARCINOMA CELLS//N6 ISOPENTENYLADENOSINE
6 0.0000099256 CAK//CDC2//CYCLIN A1
7 0.0000073252 P TEFB//CDK9//HEXIM1
8 0.0000068015 INDIRUBIN//TRYPTANTHRIN//ISATIS TINCTORIA
9 0.0000067355 BMIC//APOPTOTIC INDUCTION//IN VIVO ANTIFUNGAL ACTIVITIES
10 0.0000061394 E2F//P107//P130